###begin article-title 0
The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Considering that a portion of the heterogeneity amongst previous replication studies may be due to a variable proportion of obese subjects in case-control designs, we assessed the association of genetic variants with type 2 diabetes (T2D) in large groups of obese and non-obese subjects.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RETN</italic>
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A</italic>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
We genotyped RETN, KCNJ11, HNF4A, HNF1A, GCK, SLC30A8, ENPP1, ADIPOQ, PPARG, and TCF7L2 polymorphisms in 1,283 normoglycemic (NG) and 1,581 T2D obese individuals as well as in 3,189 NG and 1,244 T2D non-obese subjects of European descent, allowing us to examine T2D risk over a wide range of BMI.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK </italic>
###xml 147 149 147 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 184 186 184 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 228 230 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-23</sup>
###xml 284 290 284 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 311 313 311 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 352 354 352 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 390 392 390 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 488 490 488 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 500 507 500 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 530 532 530 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 565 567 565 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 580 587 580 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 609 611 609 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 621 623 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 664 670 664 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 687 689 687 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK </italic>
###xml 721 723 721 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 735 743 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 761 763 761 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 826 833 826 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 844 846 844 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 856 858 856 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 864 870 864 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 877 879 877 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 926 932 926 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RETN</italic>
###xml 944 950 944 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A </italic>
Amongst non-obese individuals, we observed significant T2D associations with HNF1A I27L [odds ratio (OR) = 1.14, P = 0.04], GCK -30G>A (OR = 1.23, P = 0.01), SLC30A8 R325W (OR = 0.87, P = 0.04), and TCF7L2 rs7903146 (OR = 1.89, P = 4.5 x 10-23), and non-significant associations with PPARG Pro12Ala (OR = 0.85, P = 0.14), ADIPOQ -11,377C>G (OR = 1.00, P = 0.97) and ENPP1 K121Q (OR = 0.99, P = 0.94). In obese subjects, associations with T2D were detected with PPARG Pro12Ala (OR = 0.73, P = 0.004), ADIPOQ -11,377C>G (OR = 1.26, P = 0.02), ENPP1 K121Q (OR = 1.30, P = 0.003) and TCF7L2 rs7903146 (OR = 1.30, P = 1.1 x 10-4), and non-significant associations with HNF1A I27L (OR = 0.96, P = 0.53), GCK -30G>A (OR = 1.15, P = 0.12) and SLC30A8 R325W (OR = 0.95, P = 0.44). However, a genotypic heterogeneity was only found for TCF7L2 rs7903146 (P = 3.2 x 10-5) and ENPP1 K121Q (P = 0.02). No association with T2D was found for KCNJ11, RETN, and HNF4A polymorphisms in non-obese or in obese individuals.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Genetic variants modulating insulin action may have an increased effect on T2D susceptibility in the presence of obesity, whereas genetic variants acting on insulin secretion may have a greater impact on T2D susceptibility in non-obese individuals.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Type 2 diabetes (T2D) is characterized by defects in both insulin sensitivity and beta-cell dysfunction [1]. This disease involves a complex interaction between genetic variants and environment with obesity established as a primary risk factor [2]. In this regard, correlations between increased body fat and insulin resistance have been reliably demonstrated [3]. Recently, associations between polymorphisms and T2D were shown to be modulated according to obesity status.
###end p 11
###begin p 12
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 487 494 487 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 664 669 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 776 783 776 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
ENPP1, ADIPOQ, PPARG and TCF7L2 single nucleotide polymorphisms (SNPs) have previously been associated with T2D [4-7] and have shown variable significance amongst different classes of obesity. It has been suggested that the ENPP1 K121Q and ADIPOQ -11,391G>A and -11,377C>G variants may confer greater T2D susceptibility in obese populations [8-10]. PPARG Pro12Ala, though controversial, was more associated with T2D amongst obese subgroups in our previous study [11-13]. Conversely, the TCF7L2 rs7903146 T allele has been shown to be more prevalent in T2D non-obese individuals compared to T2D obese subjects [7]. Interestingly, the variants in PPARG, ADIPOQ, and ENPP1, which elevate risk in obese populations, have been categorized as acting on insulin resistance while the TCF7L2 variant elevating risk in lean populations has been categorized as acting on insulin secretion [14-17]. These preliminary results suggest that different genetic architectures could increase T2D susceptibility according to the presence or absence of obesity.
###end p 12
###begin p 13
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RETN </italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A </italic>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK </italic>
###xml 282 290 282 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
Based on these observations, we have chosen to confirm previous findings and evaluate additional genetic variants which have a reported effect on either insulin action (RETN -420C>G) [18] or insulin secretion (KCNJ11 E23K, HNF4A rs1884614 and rs2144908, HNF1A I27L, GCK -30G>A, and SLC30A8 R325W) [19-25] and which have previously been associated with T2D in large scale studies or meta-analysis [21,26-30]. The evaluated variants were tested for their differential association with T2D in obese [1,283 normoglycemic (NG) and 1,581 T2D] and non-obese subjects (3,189 NG and 1,244 T2D) of European descent.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study population
###end title 15
###begin p 16
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
All NG and T2D subjects were recruited in three different centers, two in France and one in Switzerland. The clinical characteristics of the studied groups are presented in Table 1.
###end p 16
###begin p 17
Clinical characteristics and cohort distribution of the study population
###end p 17
###begin p 18
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P-values are from linear regression models adjusted for gender and age
###end p 18
###begin p 19
NG: Normoglycemic
###end p 19
###begin p 20
T2D: Type 2 Diabetic
###end p 20
###begin p 21
na: Not available
###end p 21
###begin p 22
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Non-obese: BMI < 30 kg/m2
###end p 22
###begin p 23
###xml 22 23 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Obese: BMI >/= 30 kg/m2
###end p 23
###begin p 24
Age and BMI data presented as 'mean +/- standard deviation'
###end p 24
###begin p 25
Unrelated NG and T2D French white adults were recruited using a multimedia campaign run by the "Centre National de la Recherche Scientifique" (CNRS), the Department of Nutrition of the Paris Hotel-Dieu Hospital and the Pasteur Institute of Lille.
###end p 25
###begin p 26
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
Individuals both non-obese and NG (n = 2,122) of the French general population, aged between 30 and 65 years, participated in the cohort for the Data From an Epidemiological Study on the Insulin Resistance syndrome (D.E.S.I.R.), a 9-year follow-up study that aims to clarify the development of the insulin resistance syndrome and described previously [31]. Ethnic origin cannot be legally documented in France. We estimated the proportion of subjects having non-European ancestry from a subgroup of 654 subjects selected in the D.E.S.I.R. cohort, as previously described [32]. We genotyped 328 SNPs which were spaced by at least 5 Mb and highly differentiated among individuals from different continents (Fst > 0.2 based on the Perlegen dataset) [33]. Analysis using the STRUCTURE software identified only two individuals of non-european ancestry in a total of 654 individuals. From this analysis, the proportion of subjects having non-European ancestry was estimated to be 0.30% in the D.E.S.I.R. cohort. Additionally, all individuals born outside France were excluded from the study.
###end p 26
###begin p 27
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
All NG and T2D Swiss white obese individuals were from Bern and Zurich as described previously [34]. They were added to the French samples of the same corpulence category. No heterogeneities were found between these two population groups for all SNPs [see Additional file 1].
###end p 27
###begin p 28
###xml 353 354 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 383 384 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
In all centers, two classes of glycemic status were defined according to the 1997 American Diabetes Association criteria: NG, defined as fasting glucose < 6.1 mmol/l and T2D, defined as fasting plasma glucose >/= 7.0 mmol/l. Two separate BMI categories were analyzed in this study, according to WHO international classification: non-obese (BMI < 30 kg/m2), and obese (BMI >/= 30 kg/m2).
###end p 28
###begin p 29
###xml 152 164 <span type="species:ncbi:9606">participants</span>
This genetic study was approved by the Ethical Committee of Hotel-Dieu in Corbeil-Essonnes and CHRU in Lille and informed consent was obtained from all participants.
###end p 29
###begin title 30
SNP genotyping
###end title 30
###begin p 31
###xml 81 85 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 656 657 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
High-throughput genotyping of all genetic variants was performed using the TaqMan(R) SNP Genotyping Assays (Applied Biosystems, Foster City, Calif. USA). The PCR primers and TaqMan probes were designed by Primer Express and optimized according to the manufacturer's protocol. There was a 96-99% genotyping success rate for all SNPs and the genotyping error rate was assessed by randomly genotyping 384 control and 384 T2D individuals. No difference was found from the first genotyping results, thus the genotyping error rate was 0% for each SNP. The genotypic distributions for all SNPs were in Hardy-Weinberg equilibrium (P >/= 0.01) [see Additional file 2].
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 478 480 478 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The association with T2D was calculated using a logistic regression model adjusted for age, gender, and BMI. The minimum detectable effect size with a statistical power of 80% was assessed using Quanto [see Additional file 3]. The Woolf test was applied to asses the genotypic heterogeneity between obese and non-obese groups. No Bonferroni correction was applied as, in the case of replication studies, it is unlikely to detect effects due to statistical fluctuation only. All P values are two-sided. SPSS (version 14.0.2) and R statistics (version 2.5.0) software were used for general statistics.
###end p 33
###begin title 34
Results
###end title 34
###begin p 35
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
All SNPs were evaluated for their contribution to T2D in the complete sample population (4,472 NG and 2,825 T2D), then in obese individuals (1,283 NG and 1,581 T2D) and non-obese subjects (3,189 NG and 1,244 T2D). Clinical characteristics and allelic distributions of the study population are summarized in Table 1 and Table 2, respectively. The best fitting genetic models were selected from previous studies [5-7,13,26-30,35] and were in agreement with what we found in our analyses (data not shown).
###end p 35
###begin p 36
Genotypic distributions in obese and non-obese subjects by glycemic status
###end p 36
###begin p 37
Data presented as Frequency (n)
###end p 37
###begin p 38
T2D: Type 2 diabetic
###end p 38
###begin p 39
NG: Normoglycemic
###end p 39
###begin p 40
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Non-obese: BMI < 30 kg/m2
###end p 40
###begin p 41
###xml 22 23 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Obese: BMI >/= 30 kg/m2
###end p 41
###begin p 42
1: Major allele
###end p 42
###begin p 43
2: Minor allele
###end p 43
###begin title 44
All NG and T2D Individuals
###end title 44
###begin p 45
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 250 252 250 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 262 269 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 291 293 291 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-27</sup>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 337 339 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK </italic>
###xml 392 394 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 407 415 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 433 435 433 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
We first evaluated the genetic variants amongst all NG and T2D individuals regardless of obesity status (Table 3). As previously reported in a more modestly-sized French set, T2D associations were confirmed in PPARG Pro12Ala [odds ratio (OR) = 0.81, P = 0.004], TCF7L2 rs7903146 (OR = 1.59, P = 7.9 x 10-27), and ENPP1 K121Q (OR = 1.15, P = 0.01) [7-9,11]. Additionally, GCK -30G>A (OR 1.20, P = 0.001) and SLC30A8 R325W (OR = 0.91, P = 0.03) were also found to increase T2D risk.
###end p 45
###begin p 46
Type 2 diabetes case-control study by obesity status
###end p 46
###begin p 47
Odds ratios were adjusted for age, gender and BMI
###end p 47
###begin p 48
Woolf test: Test for heterogeneity in genotypic distribution between obese and non-obese subjects
###end p 48
###begin p 49
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Non-obese: BMI < 30 kg/m2
###end p 49
###begin p 50
###xml 22 23 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Obese: BMI >/= 30 kg/m2
###end p 50
###begin p 51
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 137 139 137 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 174 176 174 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 208 210 208 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A </italic>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 292 294 292 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 303 310 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RETN </italic>
###xml 365 367 365 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
In contrast, in our whole sample analysis, no evidence for association with T2D was found for the ADIPOQ variants -11,391G>A (OR = 0.99, P = 0.91) and -11,377C>G (OR = 1.08, P = 0.18), HNF1A I27L (OR = 1.01, P = 0.71), HNF4A variants rs1884614 (OR = 1.03, P = 0.58) and rs2144908 (OR = 1.04, P = 0.45), KCNJ11 E23K (OR = 0.9, P = 0.09), or RETN -420C>G (OR = 1.00, P = 0.99).
###end p 51
###begin title 52
Non-Obese T2D Association
###end title 52
###begin p 53
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 142 144 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK </italic>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 213 215 213 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 257 259 257 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-23</sup>
We then assessed the genetic variants amongst the non-obese population (BMI < 30 kg/m2) (Table 3). The risk alleles of HNF1A I27L (OR = 1.14, P = 0.04), GCK -30G>A (OR = 1.23, P = 0.01), SLC30A8 R325W (OR = 0.87, P = 0.04), and TCF7L2 rs7903146 (OR = 1.89, P = 4.5 x 10-23) conferred a significantly increased risk of T2D.
###end p 53
###begin p 54
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 80 82 80 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 126 132 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 153 155 153 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RETN </italic>
###xml 189 191 189 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 224 226 224 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A </italic>
###xml 276 278 276 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 312 314 312 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The ADIPOQ variants -11,391G>A (OR = 0.96, P = 0.71) and -11,377C>G (OR = 1.00, P = 0.97), ENPP1 K121Q (OR = 0.99, P = 0.94), PPARG Pro12Ala (OR = 0.85, P = 0.14), RETN -420C>G (OR = 0.41, P = 0.14), KCNJ11 E23K (OR = 0.96, P = 0.68), and HNF4A variants rs1884614 (OR = 1.05, P = 0.54) and rs2144908 (OR = 1.08, P = 0.33) were not associated with T2D amongst the non-obese group.
###end p 54
###begin title 55
Obese T2D Association
###end title 55
###begin p 56
###xml 35 36 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 78 84 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 103 105 101 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 115 122 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 145 147 143 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 157 163 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 181 183 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 196 203 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 225 227 223 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 237 239 235 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 248 249 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
In the obese group (BMI >/= 30 kg/m2), associations with T2D were detected in PPARG Pro12Ala (OR 0.73, P = 0.004), ADIPOQ -11,377C>G (OR = 1.25, P = 0.015), ENPP1 K121Q (OR = 1.30, P = 0.003) and TCF7L2 rs7903146 (OR = 1.30, P = 1.1 x 10-4) (Table 3).
###end p 56
###begin p 57
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK </italic>
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 116 118 116 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 150 152 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A </italic>
###xml 198 200 198 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 269 271 269 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 283 291 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 309 311 309 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
We did not find evidence for increased T2D risk for GCK -30G>A (OR = 1.15, P = 0.12), ADIPOQ -11,391G>A (OR = 1.07, P = 0.58), HNF1A I27L (OR = 0.96, P = 0.53), HNF4A variants rs1884614 (OR = 1.05, P = 0.54) and rs2144908 (OR = 1.04, P = 0.63), KCNJ11 E23K (OR = 0.96, P = 0.68), or SLC30A8 R325W (OR = 0.95, P = 0.44) amongst obese subjects.
###end p 57
###begin title 58
Genotypic heterogeneity
###end title 58
###begin p 59
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 180 182 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 213 215 213 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 465 472 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 482 484 482 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 508 510 508 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Discrepancies in genotypic distribution were assessed by Woolf test between the obese and non-obese categories (Table 3). A genotypic heterogeneity was found for TCF7L2 rs7903146 (P = 3.2 x 10-5) and ENPP1 K121Q (P = 0.02). Their association with BMI change was then assessed in all studied subgroups. Significant effects on BMI were only detected in the T2D group for the TCF7L2 genetic variant [see Additional file 4]. Trends towards heterogeneity were found for ADIPOQ 11377C>G (P = 0.07) and HNF1A I27L (P = 0.06).
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A</italic>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 260 268 260 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8 </italic>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 504 510 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 535 542 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
This large case-control study further supports the hypothesis that the T2D risk contribution of ENPP1, ADIPOQ, PPARG and TCF7L2 SNPs may be modulated by obesity status [6-8,11]. Notably, we made the novel finding that T2D risk, as conferred by HNF1A, GCK, and SLC30A8 genetic variants, may also be modified in the presence/absence of obesity. Despite the stringent standards exacted by the Woolf test, genotypic heterogeneity between obese and non-obese individuals was detected for TCF7L2 rs7903146 and ENPP1 K121Q, and suggested for ADIPOQ 11377C>G and HNF1A I27L SNPs. Future study designs containing more individuals will be needed to confirm all apparent genotypic heterogeneities.
###end p 61
###begin p 62
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4A</italic>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11 </italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RETN </italic>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The analysis of HNF4A, KCNJ11 and RETN polymorphisms did not support their role as T2D risk factors despite sufficient statistical power [see Additional file 3] to detect the effect sizes (1.08, 1.09 and 1.16, respectively) previously established by meta-analysis [21,26,27]. The inability of the current study to replicate previous findings is likely the result of true but modest contributions to T2D risk in the European population.
###end p 62
###begin p 63
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCK</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1A </italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 360 367 360 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 582 589 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ </italic>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
While it is known that defects in insulin action and insulin secretion are critical in T2D pathogenesis, their interaction with genetic and environmental factors is less clear. Interestingly, SLC30A8, GCK, and HNF1A genetic variants, all of which have been associated with insulin secretion [22-25], were only associated with T2D in non-obese individuals. The TCF7L2 genetic variant, another SNP modulating beta cell function [17,36], was more associated with T2D in non-obese subjects than in obese individuals. Conversely, insulin resistance associated genetic variants of PPARG, ADIPOQ and ENPP1 [14-16,37,38] were found to be only associated in obese subjects. While obesity has been strongly associated with increased insulin resistance [3], our data suggests that insulin secretory variants confer a greater T2D risk in non-obese individuals while insulin sensitivity variants more significantly modulate T2D risk in obese subjects.
###end p 63
###begin p 64
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 549 561 <span type="species:ncbi:9606">participants</span>
Currently, some dissension exists regarding the BMI modulation of the Pro12Ala SNP in T2D risk. Contrary to what was reported by Ghoussaini and colleagues [11], other studies of the PPARG Pro12Ala SNP suggest that the protective effect of the Ala allele may be greater when control BMI is lower [12,13]. The present analysis was specifically designed to detect interactions by analyzing a large number of European subjects with no genotypic heterogeneity and characterized by a wide range of BMI. In the "Diabetes Prevention Program", 55 percent of participants were Caucasian, 45 percent were minorities, most were obese, and most had a family history of T2D [12]. Similarly, Ludivico and colleagues performed a combined analysis of Asian, North American, and European populations. Interestingly, the genetic effect on T2D was found to be ~30% stronger in Asians than in the two other more corpulent populations [13]. We therefore suggest that population heterogeneity may be the primary contributor to the overall observed BMI effect as supported by the ability of BMI to statistically explain the heterogeneity between these populations but not within Europeans [13]. Large ethnically-matched studies would be necessary to know if such interaction is found in non-European subjects.
###end p 64
###begin p 65
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 512 514 512 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 577 579 577 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 687 689 687 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
These results illustrate the importance of BMI in population design as obesity mediated T2D associations may account for part of the difficulty encountered in replication studies. The ENPP1 K121Q variant may be illustrative of this point. Studies exploring the T2D risk contribution of the K121Q SNP amongst obese individuals [8,10] have found an enhanced association in this subgroup. In the present study, we supported these results in finding no significant effect on T2D in non-obese individuals (OR = 0.99, P = 0.94), an association with T2D in obese subjects (OR = 1.30, P = 0.003) and a subsequent modest effect when obese and non-obese samples were analyzed together (OR = 1.15, P = 0.01). A portion of the heterogeneity amongst previous replication studies may be due to a variable fraction of obese subjects in study designs [5,8,39,40]. Considering these results, future association studies should take into account obesity status when interpreting their data.
###end p 65
###begin p 66
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
A representation of the possible relationship between T2D risk variants and obesity status is modeled in Figure 1. This study suggests that the magnitude of a variant's effect on T2D susceptibility is modulated by both obesity status and SNP function. Specifically, variants effecting insulin action more significantly increase T2D susceptibility in obese individuals while variants effecting insulin secretion confer greater T2D risk in non-obese individuals. In our study, data on waist/hip ratio were not available in most T2D cases. However, further analyses of the issue should consider this anthropometric parameter when analyzing interactions between obesity and T2D.
###end p 66
###begin p 67
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional relevance of genetic variants may affect their association with T2D by obesity status</bold>
Functional relevance of genetic variants may affect their association with T2D by obesity status. The present figure does not take into account variants associated with T2D through their effect on BMI.
###end p 67
###begin p 68
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
These data are concordant with results from previous epidemiological and physiological studies. Prospective data indicates that impaired beta cell function, not insulin resistance, predicts future T2D in non-obese subjects [41]. Furthermore, it was recently reported that interactions between TCF7L2 genetic variants and adiposity may lead to reduced beta-cell compensation in leaner individuals but facilitate improved compensation in more obese subjects [42]. Increased beta-cell mass has indeed been observed in the pancreata of obese compared to lean non-diabetic subjects [43]. These results support a primary role of insulin secretory modulating variants in the absence of obesity. Conversely, the hyperbolic relationship of insulin resistance and insulin secretion enables the beta-cell to adequately maintain glucose homeostasis for a large range of insulin resistance levels [44]. In non-obese subjects not affected by adiposity-induced insulin resistance, this mechanism may sufficiently compensate the effects of genetic variants increasing insulin resistance.
###end p 68
###begin p 69
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 709 715 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 721 727 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 597 603 <span type="species:ncbi:10090">murine</span>
Obesity-induced insulin resistance is characterized by a series of events: i) impaired regulation of lipolysis in adipocytes, ii) increased circulating levels of free fatty acids [45], iii) ectopic fat storage in muscle and liver, iv) impaired ability of insulin to inhibit hepatic glucose production and muscular glucose uptake [46], v) increased beta cell death by apoptosis (glucolipotoxicity) [43,47]. In obesity-prone populations, insulin resistance more accurately predicts development of T2D than does insulin secretory dysfunction [48]. Previous studies on lipodistrophy in both human and murine models have shown that adipose tissue plays a key role in insulin resistance [49]. Interestingly, PPARG, ADIPOQ, and ENPP1 SNPs only associated with T2D in obese subjects, and have a pivotal role in adipocyte differentiation, maturation, and action [50-52]. The effects of genetic polymorphisms leading to insulin resistance may therefore be worsened by obesity.
###end p 69
###begin p 70
In the present study, we suggested that the genetic architecture of T2D may be different in obese and non-obese individuals. In a given ethnic group, the lack of replication in association studies may be, in part, due to different fractions of obesity in case-control designs. Novel SNPs recently identified in genome-wide association studies will prove important in the confirmation of these findings once their functions have been reliably demonstrated.
###end p 70
###begin title 71
Abbreviations
###end title 71
###begin p 72
T2D: Type 2 Diabetes; NG: Normoglycemic; BMI: Body Mass Index; OR: Odds ratio; SNP: Single Nucleotide Polymorphism.
###end p 72
###begin title 73
Competing interests
###end title 73
###begin p 74
The authors declare that they have no competing interests.
###end p 74
###begin title 75
Authors' contributions
###end title 75
###begin p 76
SC managed the study, carried out the genetic analyses and drafted the manuscript. KTN carried out the genetic analyses, drafted the manuscript and carried out the genotyping experiments. HC carried out the genotyping experiments. FH participated in the design of the study. NP participated in the design of the database. BB participated in the design of the study. MM participated in the design of the study. GC participated in the design of the study. PF coordinated the study. DM conceived the study, and participated in its design and coordination. All authors read and approved the final manuscript.
###end p 76
###begin title 77
Pre-publication history
###end title 77
###begin p 78
The pre-publication history for this paper can be accessed here:
###end p 78
###begin p 79

###end p 79
###begin title 80
Supplementary Material
###end title 80
###begin title 81
Additional file 1
###end title 81
###begin p 82
Supplementary table 1. Homogeneity in genotypic distributions between Swiss and French subjects
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 2
###end title 84
###begin p 85
Supplementary table 2. Hardy-Weinberg equilibrium for each studied SNP
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Additional file 3
###end title 87
###begin p 88
Supplementary table 3. Minimum detectable effect size with a statistical power of 80%.
###end p 88
###begin p 89
Click here for file
###end p 89
###begin title 90
Additional file 4
###end title 90
###begin p 91
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1 </italic>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
Supplementary table 4. BMI distribution by ENPP1 and TCF7L2 genotypes.
###end p 91
###begin p 92
Click here for file
###end p 92
###begin title 93
Acknowledgements
###end title 93
###begin p 94
###xml 59 91 59 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Agence Nationale de la Recherche</italic>
###xml 114 153 114 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Association Fran&#231;aise des Diab&#233;tiques" </italic>
###xml 158 204 158 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Programme national de recherche sur le diab&#232;te</italic>
This work was partly supported by the French Governmental "Agence Nationale de la Recherche", and the charities: "Association Francaise des Diabetiques" and "Programme national de recherche sur le diabete". We thank Marianne Deweider and Frederic Allegaert for the DNA bank management and Stefan Gaget for his help on phenotype databases. We are indebted to all subjects who participated to this study.
###end p 94
###begin article-title 95
Type 2 diabetes: principles of pathogenesis and therapy
###end article-title 95
###begin article-title 96
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
###end article-title 96
###begin article-title 97
Mechanisms linking obesity to insulin resistance and type 2 diabetes
###end article-title 97
###begin article-title 98
The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects
###end article-title 98
###begin article-title 99
Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects
###end article-title 99
###begin article-title 100
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians
###end article-title 100
###begin article-title 101
Effects of TCF7L2 Polymorphisms on Obesity in European Populations
###end article-title 101
###begin article-title 102
Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes
###end article-title 102
###begin article-title 103
Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity
###end article-title 103
###begin article-title 104
New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals
###end article-title 104
###begin article-title 105
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population
###end article-title 105
###begin article-title 106
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone
###end article-title 106
###begin article-title 107
Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk
###end article-title 107
###begin article-title 108
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
###end article-title 108
###begin article-title 109
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
###end article-title 109
###begin article-title 110
Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit
###end article-title 110
###begin article-title 111
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
###end article-title 111
###begin article-title 112
The hormone resistin links obesity to diabetes
###end article-title 112
###begin article-title 113
The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes
###end article-title 113
###begin article-title 114
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism
###end article-title 114
###begin article-title 115
Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians
###end article-title 115
###begin article-title 116
Common variants in HNF-1 alpha and risk of type 2 diabetes
###end article-title 116
###begin article-title 117
Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance
###end article-title 117
###begin article-title 118
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
###end article-title 118
###begin article-title 119
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
###end article-title 119
###begin article-title 120
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3
###end article-title 120
###begin article-title 121
Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses
###end article-title 121
###begin article-title 122
Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population
###end article-title 122
###begin article-title 123
Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes
###end article-title 123
###begin article-title 124
Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes
###end article-title 124
###begin article-title 125
[An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]
###end article-title 125
###begin article-title 126
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 126
###begin article-title 127
###xml 55 60 <span type="species:ncbi:9606">human</span>
Whole-genome patterns of common DNA variation in three human populations
###end article-title 127
###begin article-title 128
Binge eating as a major phenotype of melanocortin 4 receptor gene mutations
###end article-title 128
###begin article-title 129
Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes
###end article-title 129
###begin article-title 130
###xml 166 169 <span type="species:ncbi:9606">men</span>
Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men
###end article-title 130
###begin article-title 131
###xml 197 203 <span type="species:ncbi:9606">humans</span>
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans
###end article-title 131
###begin article-title 132
The K121Q polymorphism of the PC-1 gene is associated with insulin resistance but not with dyslipidemia
###end article-title 132
###begin article-title 133
The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction
###end article-title 133
###begin article-title 134
No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians
###end article-title 134
###begin article-title 135
K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years
###end article-title 135
###begin article-title 136
Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans
###end article-title 136
###begin article-title 137
###xml 55 61 <span type="species:ncbi:9606">humans</span>
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
###end article-title 137
###begin article-title 138
###xml 127 132 <span type="species:ncbi:9606">women</span>
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance
###end article-title 138
###begin article-title 139
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
###end article-title 139
###begin article-title 140
Insulin signalling and the regulation of glucose and lipid metabolism
###end article-title 140
###begin article-title 141
Islet beta cell failure in type 2 diabetes
###end article-title 141
###begin article-title 142
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
###end article-title 142
###begin article-title 143
Lipodystrophies
###end article-title 143
###begin article-title 144
###xml 31 36 <span type="species:ncbi:9606">human</span>
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
###end article-title 144
###begin article-title 145
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
###end article-title 145
###begin article-title 146
Role of ENPP1 on adipocyte maturation
###end article-title 146

